Incidence trends and familial risks in invasive and in situ cutaneous melanoma by sun-exposed body sites

International Journal of Cancer

Volumn 104, Issue 6, 2003, Pages 764-771

  Hemminki, Kari ^a,b,c   Zhang, Hong ^a   Czene, Kamila ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c CNT Novum   (Sweden)

Author keywords

Familial cancer; Gene environment interaction; Heredity; Parent offspring risks; Sibling risks

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; ENVIRONMENTAL EXPOSURE; FAMILIAL CANCER; FEMALE; HIGH RISK POPULATION; HUMAN; LENTIGO; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; SIBLING; SKIN CANCER; SOLAR RADIATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; REGISTRIES; RISK FACTORS; SKIN NEOPLASMS; SUNLIGHT; SWEDEN;

EID: 0037431509     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10976     Document Type: Article

References (48)

1. IARC. GLOBOCAN 2000. Cancer incidence, mortality and prevalence worldwide. In: Ferlay J, Bray F, Pisani P, Parkin M, eds. Lyon: IARC, 2001.
2. Centre for Epidemiology. Cancer incidence in Sweden 2000. Stockholm: The National Board of Health and Welfare, 2002.
3. Hemminki K, Li X, Czene K. Cancer risks in first generation immigrants to Sweden. Int J Cancer 2002;99:218-28.
4. Hemminki K, Li X. Cancer risks in second-generation immigrants to Sweden. Int J Cancer 2002;99:229-37.
5. Wassberg C, Thorn M, Yuen J, Hakulinen T, Ringborg U. Cancer risk in patients with earlier diagnosis of cutaneous melanoma in situ. Int J Cancer 1999;83:314-7.
6. Howe HL, Wingo PA, Thun MJ, Ries LA, Rosenberg HM, Feigal EG, Edwards BK. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001;93:824-42.
7. MacKie RM, Bray C, Hole D, Morris A, Nicolson M, Evans A, Doherty V, Vestey J. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet 2002;360:587-91.
8. Cox NH, Aitchison TC, Sirel JM, MacKie RM. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group. Br J Cancer 1996;73:940-4.
9. Mansson-Brahme E, Johansson H, Larsson O, Rutqvist LE, Ringborg U. Trends in incidence of cutaneous malignant melanoma in a Swedish population 1976-1994. Acta Oncol 2002;41:138-46.
10. Elwood J. Melanoma and ultraviolet radiation. Clin Dematol 1992;10:41-50.
11. English D, Armstrong B, Kricker A, Fleming C. Sunlight and cancer. Cancer Causes Control 1997;8:271-83.
12. Elwood JM, Gallagher RP, Worth AJ, Wood WS, Pearson JC. Etiological differences between subtypes of cutaneous malignant melanoma: Western Canada Melanoma Study. J Natl Cancer Inst 1987;78:37-44.
13. Elwood JM, Gallagher RP. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. Int J Cancer 1998;78:276-80.
14. Gillgren P, Mansson-Brahme E, Frisell J, Johansson H, Larsson O, Ringborg U. Epidemiological characteristics of cutaneous malignant melanoma of the head and neck - a population-based study. Acta Oncol 1999;38:1069-74.
15. Chamberlain AJ, Fritschi L, Giles GG, Dowling JP, Kelly JW. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol 2002;138:609-14.
16. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600-7.
17. Hemminki K, Lönnstedt I, Vaittinen P. A population-based study of familial cutaneous melanoma. Melanoma Res 2001;11:133-40.
18. Hemminki K, Vaittinen P. Familial cancers in a nation-wide family-cancer database: age distribution and prevalence. Eur J Cancer 1999;35:1109-11.
19. Goldstein A, Tucker M. Genetic epidemiology of familial melanoma. Dermatol Clin 1995;13:605-12.
20. Ang C, Kelly J, Fritschi L, Dowling J. Characteristics of familial and non-familial melanoma in Australia. Melanoma Res 1998;8:459-64.
21. Greene M. The genetics of hereditary melanoma and nevi: 1998 update. Cancer 1999;86(S 11):2464-77.
22. Zhu G, Duffy D, Eldridge A, Grace M, Mayne C, O'Gorman L, Aitken J, Neale M, Hayward N, Greene A, Martin N. A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. Am J Hum Genet 1999;65:483-92.
23. Wachsmuth RC, Gaut RM, Barrett JH, Saunders CL, Randerson-Moor JA, Eldridge A, Martin NG, Bishop TD, Newton Bishop JA. Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study. J Invest Dermatol 2001;117:348-52.
24. Harrison SL, MacKie RM, MacLennan R. Development of melanocytic nevi in the first three years of life. J Natl Cancer Inst 2000;92:1436-8.
25. Landi MT, Baccarelli A, Calista D, Pesatori A, Fears T, Tucker MA, Landi G. Combined risk factors for melanoma in a Mediterranean population. Br J Cancer 2001;85:1304-10.
26. Landi MT, Baccarelli A, Tarone RE, Pesatori A, Tucker MA, Hedayati M, Grossman L. DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma. J Natl Cancer Inst 2002;94:94-101.
27. Harland M, Meloni R, Gruis N, Pinney E, Brookes S, Spurr N, Frischauf AM, Bataille V, Peters G, Cuzick J, Selby P, Bishop DT, et al. Germline mutations of the CDKN2 gene in UK melanoma families. Hum Mol Genet 1997;6:2061-7.
28. Platz A, Hansson J, Mansson-Brahme E, Langerlof B, Linder S, Lundqvist E, Sevigny P, Inganas M, Ringborg U. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma. J Natl Cancer Inst 1997;89:697-702.
29. Aitken J, Welch J, Duffy D, Milligan A, Green A, Martin N, Hayward N. CDKN2A variants in a population-based sample of Queensland families with melanoma. J Natl Cancer Inst 1999;91:446-52.
30. Kumar R, Smeds J, Berggren P, Straume O, Rozell BL, Akslen LA, Hemminki K. A single nucleotide polymorphism in the 3′ untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare. Int J Cancer 2001;95:388-93.
31. Staume O, Smeds J, Kumar R, Hemminki K, Akslen L. Significant impact of promoter hypermethylation and the 540 C→T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase. Am J Pathol 2002;161:229-37.
32. Rees J. The melanocortin 1 receptor (MC1R): more than just red hair. Pigment Cell Res 2000;13:135-40.
33. Schaffer J, Bolognia J. The melanocortin-1 receptor: red hair and beyond. J Invest Dermatol 2001;137:1477-85.
34. Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R, Bavinck JN. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001;117:294-300.
35. van der Velden PA, Sandkuijl LA, Bergman W, Pavel S, van Mourik L, Frants RR, Gruis NA. Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet 2001;69:774-9.
36. Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiological review. J Natl Cancer Inst 2000;92:874-97.
37. Xu G, Snellman E, Bykov VJ, Jansen CT, Hemminki K. Cutaneous melanoma patients have normal repair kinetics of ultraviolet-induced DNA repair in skin in situ. J Invest Dermatol 2000;114:628-31.
38. Zhao C, Snellman E, Jansen CT, Hemminki K. In situ repair of cyclobutane pyrimidine dimers in skin and melanocytic nevi of cutaneous melanoma patients. Int J Cancer 2002;98:331-4.
39. Bishop DT, Demenais F, Goldstein AM, Bergman W, Bishop JN, Paillerets BB, Chompret A, Ghiorzo P, Gruis N, Hansson J, Harland M, Hayward N, et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 2002;94:894-903.
40. Siskind V, Aitken J, Green A, Martin N. Sun exposure and interaction with family history in risk of melanoma, Queensland, Australia. Int J Cancer 2002;97:90-5.
41. Hemminki K, Vaittinen P. National database of familial cancer in Sweden. Genet Epidemiol 1998;15:225-36.
42. Hemminki K, Vaittinen P, Kyyrönen P. Age-specific familial risks in common cancers of the offspring. Int J Cancer 1998;78:172-5.
43. Hemminki K, Li X, Plna K, Granström C, Vaittinen P. The nationwide Swedish Family-Cancer Database: updated structure and familial rates. Acta Oncol 2001;40:772-7.
44. Esteve J, Benhamou E, Raymond L. Statistical methods in cancer research, vol. 128. Lyon: IARC, 1994.
45. Hemminki K, Vaittinen P, Dong C, Easton D. Sibling risks in cancer: clues to recessive or X-linked genes? Br J Cancer 2001;84:388-91.
46. Boldeman C, Branstrom R, Dal H, Kristjansson S, Rodvall Y, Jansson B, Ullen H. Tanning habits and sunburn in a Swedish population age 13-50 years. Eur J Cancer 2001;37:2441-8.
47. Dong C, Hemminki K. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 2001;91:144-50.
48. Hemminki K, Li X. Gender effects in familial cancer. Int J Cancer 2002;102:184-7.